Global Oncology Biosimilars Sales Market Report 2019

Table of Contents

Global Oncology Biosimilars Sales Market Report 2017
1 Oncology Biosimilars Market Overview
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars by Product Category
1.2.1 Global Oncology Biosimilars Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Oncology Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 G-CSF
1.2.4 Hematopoietic Agents
1.2.5 Monoclonal Antibodies
1.3 Global Oncology Biosimilars Market by Application/End Users
1.3.1 Global Oncology Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Oncology Biosimilars Market by Region
1.4.1 Global Oncology Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Oncology Biosimilars Status and Prospect (2012-2022)
1.4.3 China Oncology Biosimilars Status and Prospect (2012-2022)
1.4.4 Europe Oncology Biosimilars Status and Prospect (2012-2022)
1.4.5 Japan Oncology Biosimilars Status and Prospect (2012-2022)
1.4.6 Southeast Asia Oncology Biosimilars Status and Prospect (2012-2022)
1.4.7 India Oncology Biosimilars Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Oncology Biosimilars (2012-2022)
1.5.1 Global Oncology Biosimilars Sales and Growth Rate (2012-2022)
1.5.2 Global Oncology Biosimilars Revenue and Growth Rate (2012-2022)

2 Global Oncology Biosimilars Competition by Players/Suppliers, Type and Application
2.1 Global Oncology Biosimilars Market Competition by Players/Suppliers
2.1.1 Global Oncology Biosimilars Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Oncology Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Oncology Biosimilars (Volume and Value) by Type
2.2.1 Global Oncology Biosimilars Sales and Market Share by Type (2012-2017)
2.2.2 Global Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Global Oncology Biosimilars (Volume and Value) by Region
2.3.1 Global Oncology Biosimilars Sales and Market Share by Region (2012-2017)
2.3.2 Global Oncology Biosimilars Revenue and Market Share by Region (2012-2017)
2.4 Global Oncology Biosimilars (Volume) by Application

3 United States Oncology Biosimilars (Volume, Value and Sales Price)
3.1 United States Oncology Biosimilars Sales and Value (2012-2017)
3.1.1 United States Oncology Biosimilars Sales and Growth Rate (2012-2017)
3.1.2 United States Oncology Biosimilars Revenue and Growth Rate (2012-2017)
3.1.3 United States Oncology Biosimilars Sales Price Trend (2012-2017)
3.2 United States Oncology Biosimilars Sales Volume and Market Share by Players
3.3 United States Oncology Biosimilars Sales Volume and Market Share by Type
3.4 United States Oncology Biosimilars Sales Volume and Market Share by Application

4 China Oncology Biosimilars (Volume, Value and Sales Price)
4.1 China Oncology Biosimilars Sales and Value (2012-2017)
4.1.1 China Oncology Biosimilars Sales and Growth Rate (2012-2017)
4.1.2 China Oncology Biosimilars Revenue and Growth Rate (2012-2017)
4.1.3 China Oncology Biosimilars Sales Price Trend (2012-2017)
4.2 China Oncology Biosimilars Sales Volume and Market Share by Players
4.3 China Oncology Biosimilars Sales Volume and Market Share by Type
4.4 China Oncology Biosimilars Sales Volume and Market Share by Application

5 Europe Oncology Biosimilars (Volume, Value and Sales Price)
5.1 Europe Oncology Biosimilars Sales and Value (2012-2017)
5.1.1 Europe Oncology Biosimilars Sales and Growth Rate (2012-2017)
5.1.2 Europe Oncology Biosimilars Revenue and Growth Rate (2012-2017)
5.1.3 Europe Oncology Biosimilars Sales Price Trend (2012-2017)
5.2 Europe Oncology Biosimilars Sales Volume and Market Share by Players
5.3 Europe Oncology Biosimilars Sales Volume and Market Share by Type
5.4 Europe Oncology Biosimilars Sales Volume and Market Share by Application

6 Japan Oncology Biosimilars (Volume, Value and Sales Price)
6.1 Japan Oncology Biosimilars Sales and Value (2012-2017)
6.1.1 Japan Oncology Biosimilars Sales and Growth Rate (2012-2017)
6.1.2 Japan Oncology Biosimilars Revenue and Growth Rate (2012-2017)
6.1.3 Japan Oncology Biosimilars Sales Price Trend (2012-2017)
6.2 Japan Oncology Biosimilars Sales Volume and Market Share by Players
6.3 Japan Oncology Biosimilars Sales Volume and Market Share by Type
6.4 Japan Oncology Biosimilars Sales Volume and Market Share by Application

7 Southeast Asia Oncology Biosimilars (Volume, Value and Sales Price)
7.1 Southeast Asia Oncology Biosimilars Sales and Value (2012-2017)
7.1.1 Southeast Asia Oncology Biosimilars Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Oncology Biosimilars Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Oncology Biosimilars Sales Price Trend (2012-2017)
7.2 Southeast Asia Oncology Biosimilars Sales Volume and Market Share by Players
7.3 Southeast Asia Oncology Biosimilars Sales Volume and Market Share by Type
7.4 Southeast Asia Oncology Biosimilars Sales Volume and Market Share by Application

8 India Oncology Biosimilars (Volume, Value and Sales Price)
8.1 India Oncology Biosimilars Sales and Value (2012-2017)
8.1.1 India Oncology Biosimilars Sales and Growth Rate (2012-2017)
8.1.2 India Oncology Biosimilars Revenue and Growth Rate (2012-2017)
8.1.3 India Oncology Biosimilars Sales Price Trend (2012-2017)
8.2 India Oncology Biosimilars Sales Volume and Market Share by Players
8.3 India Oncology Biosimilars Sales Volume and Market Share by Type
8.4 India Oncology Biosimilars Sales Volume and Market Share by Application

9 Global Oncology Biosimilars Players/Suppliers Profiles and Sales Data
9.1 Celltrion Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Oncology Biosimilars Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Celltrion Inc. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Pfizer Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Oncology Biosimilars Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Pfizer Inc. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Biocon
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Oncology Biosimilars Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 BIOCAD
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oncology Biosimilars Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 BIOCAD Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Apotex Inc.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Oncology Biosimilars Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Apotex Inc. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Dr. Reddy's Laboratories Ltd.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Oncology Biosimilars Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Dr. Reddy's Laboratories Ltd. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Sandoz International GmbH
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Oncology Biosimilars Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Sandoz International GmbH Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Intas Pharmaceuticals Ltd.
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Oncology Biosimilars Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 STADA Arzneimittel AG
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Oncology Biosimilars Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Teva Pharmaceutical Industries Ltd.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Oncology Biosimilars Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Oncology Biosimilars Maufacturing Cost Analysis
10.1 Oncology Biosimilars Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Oncology Biosimilars
10.3 Manufacturing Process Analysis of Oncology Biosimilars

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Oncology Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Oncology Biosimilars Market Forecast (2017-2022)
14.1 Global Oncology Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Oncology Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Oncology Biosimilars Price and Trend Forecast (2017-2022)
14.2 Global Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Oncology Biosimilars Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Oncology Biosimilars Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Oncology Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Oncology Biosimilars Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Oncology Biosimilars Sales Forecast by Type (2017-2022)
14.3.2 Global Oncology Biosimilars Revenue Forecast by Type (2017-2022)
14.3.3 Global Oncology Biosimilars Price Forecast by Type (2017-2022)
14.4 Global Oncology Biosimilars Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Oncology Biosimilars
Figure Global Oncology Biosimilars Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure G-CSF Product Picture
Figure Hematopoietic Agents Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Global Oncology Biosimilars Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of Oncology Biosimilars by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Oncology Biosimilars Market Size (Million USD) by Regions (2012-2022)
Figure United States Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Oncology Biosimilars Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Oncology Biosimilars Sales Volume (MT) (2012-2017)
Table Global Oncology Biosimilars Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global Oncology Biosimilars Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Oncology Biosimilars Sales Share by Players/Suppliers
Figure 2017 Oncology Biosimilars Sales Share by Players/Suppliers
Figure Global Oncology Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Oncology Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Oncology Biosimilars Revenue Share by Players
Table 2017 Global Oncology Biosimilars Revenue Share by Players
Table Global Oncology Biosimilars Sales (MT) and Market Share by Type (2012-2017)
Table Global Oncology Biosimilars Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Type (2012-2017)
Figure Global Oncology Biosimilars Sales Growth Rate by Type (2012-2017)
Table Global Oncology Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Oncology Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Type (2012-2017)
Figure Global Oncology Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Global Oncology Biosimilars Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global Oncology Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Region (2012-2017)
Figure Global Oncology Biosimilars Sales Growth Rate by Region in 2016
Table Global Oncology Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Oncology Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Region (2012-2017)
Figure Global Oncology Biosimilars Revenue Growth Rate by Region in 2016
Table Global Oncology Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Oncology Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oncology Biosimilars by Region (2012-2017)
Figure Global Oncology Biosimilars Revenue Market Share by Region in 2016
Table Global Oncology Biosimilars Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global Oncology Biosimilars Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Oncology Biosimilars by Application (2012-2017)
Figure Global Oncology Biosimilars Sales Market Share by Application (2012-2017)
Figure United States Oncology Biosimilars Sales (MT) and Growth Rate (2012-2017)
Figure United States Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Oncology Biosimilars Sales Price (USD/Kg) Trend (2012-2017)
Table United States Oncology Biosimilars Sales Volume (MT) by Players (2012-2017)
Table United States Oncology Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure United States Oncology Biosimilars Sales Volume Market Share by Players in 2016
Table United States Oncology Biosimilars Sales Volume (MT) by Type (2012-2017)
Table United States Oncology Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure United States Oncology Biosimilars Sales Volume Market Share by Type in 2016
Table United States Oncology Biosimilars Sales Volume (MT) by Application (2012-2017)
Table United States Oncology Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure United States Oncology Biosimilars Sales Volume Market Share by Application in 2016
Figure China Oncology Biosimilars Sales (MT) and Growth Rate (2012-2017)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Oncology Biosimilars Sales Price (USD/Kg) Trend (2012-2017)
Table China Oncology Biosimilars Sales Volume (MT) by Players (2012-2017)
Table China Oncology Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure China Oncology Biosimilars Sales Volume Market Share by Players in 2016
Table China Oncology Biosimilars Sales Volume (MT) by Type (2012-2017)
Table China Oncology Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure China Oncology Biosimilars Sales Volume Market Share by Type in 2016
Table China Oncology Biosimilars Sales Volume (MT) by Application (2012-2017)
Table China Oncology Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure China Oncology Biosimilars Sales Volume Market Share by Application in 2016
Figure Europe Oncology Biosimilars Sales (MT) and Growth Rate (2012-2017)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Oncology Biosimilars Sales Price (USD/Kg) Trend (2012-2017)
Table Europe Oncology Biosimilars Sales Volume (MT) by Players (2012-2017)
Table Europe Oncology Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Europe Oncology Biosimilars Sales Volume Market Share by Players in 2016
Table Europe Oncology Biosimilars Sales Volume (MT) by Type (2012-2017)
Table Europe Oncology Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Europe Oncology Biosimilars Sales Volume Market Share by Type in 2016
Table Europe Oncology Biosimilars Sales Volume (MT) by Application (2012-2017)
Table Europe Oncology Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Europe Oncology Biosimilars Sales Volume Market Share by Application in 2016
Figure Japan Oncology Biosimilars Sales (MT) and Growth Rate (2012-2017)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Oncology Biosimilars Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Oncology Biosimilars Sales Volume (MT) by Players (2012-2017)
Table Japan Oncology Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Japan Oncology Biosimilars Sales Volume Market Share by Players in 2016
Table Japan Oncology Biosimilars Sales Volume (MT) by Type (2012-2017)
Table Japan Oncology Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Japan Oncology Biosimilars Sales Volume Market Share by Type in 2016
Table Japan Oncology Biosimilars Sales Volume (MT) by Application (2012-2017)
Table Japan Oncology Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Japan Oncology Biosimilars Sales Volume Market Share by Application in 2016
Figure Southeast Asia Oncology Biosimilars Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology Biosimilars Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Oncology Biosimilars Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia Oncology Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Oncology Biosimilars Sales Volume Market Share by Players in 2016
Table Southeast Asia Oncology Biosimilars Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Oncology Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Oncology Biosimilars Sales Volume Market Share by Type in 2016
Table Southeast Asia Oncology Biosimilars Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia Oncology Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Oncology Biosimilars Sales Volume Market Share by Application in 2016
Figure India Oncology Biosimilars Sales (MT) and Growth Rate (2012-2017)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Oncology Biosimilars Sales Price (USD/Kg) Trend (2012-2017)
Table India Oncology Biosimilars Sales Volume (MT) by Players (2012-2017)
Table India Oncology Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure India Oncology Biosimilars Sales Volume Market Share by Players in 2016
Table India Oncology Biosimilars Sales Volume (MT) by Type (2012-2017)
Table India Oncology Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure India Oncology Biosimilars Sales Volume Market Share by Type in 2016
Table India Oncology Biosimilars Sales Volume (MT) by Application (2012-2017)
Table India Oncology Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure India Oncology Biosimilars Sales Volume Market Share by Application in 2016
Table Celltrion Inc. Basic Information List
Table Celltrion Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celltrion Inc. Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Celltrion Inc. Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Celltrion Inc. Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Pfizer Inc. Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Pfizer Inc. Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Biocon Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Biocon Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table BIOCAD Basic Information List
Table BIOCAD Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BIOCAD Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure BIOCAD Oncology Biosimilars Sales Global Market Share (2012-2017
Figure BIOCAD Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Apotex Inc. Basic Information List
Table Apotex Inc. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Apotex Inc. Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Apotex Inc. Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Apotex Inc. Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Dr. Reddy’s Laboratories Ltd. Basic Information List
Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Sandoz International GmbH Basic Information List
Table Sandoz International GmbH Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sandoz International GmbH Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Sandoz International GmbH Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Sandoz International GmbH Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Intas Pharmaceuticals Ltd. Basic Information List
Table Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Intas Pharmaceuticals Ltd. Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table STADA Arzneimittel AG Basic Information List
Table STADA Arzneimittel AG Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Global Market Share (2012-2017
Figure STADA Arzneimittel AG Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Sales Global Market Share (2012-2017
Figure Teva Pharmaceutical Industries Ltd. Oncology Biosimilars Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Players in 2016
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Global Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Oncology Biosimilars Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global Oncology Biosimilars Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share Forecast by Regions in 2022
Table Global Oncology Biosimilars Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share Forecast by Regions in 2022
Figure United States Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Oncology Biosimilars Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Oncology Biosimilars Sales (MT) Forecast by Type (2017-2022)
Figure Global Oncology Biosimilars Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Oncology Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Oncology Biosimilars Revenue Market Share Forecast by Type (2017-2022)
Table Global Oncology Biosimilars Price (USD/Kg) Forecast by Type (2017-2022)
Table Global Oncology Biosimilars Sales (MT) Forecast by Application (2017-2022)
Figure Global Oncology Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources